Richard A. Lerner's most recent trade in Intra-Cellular Therapies Inc was a trade of 402 Common Stock done at an average price of $37.3 . Disclosure was reported to the exchange on Sept. 30, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intra-Cellular Therapies Inc | Richard A. Lerner | Director | Grant, award, or other acquisition of securities at price $ 37.28 per share. | 30 Sep 2021 | 402 | 96,663 (0%) | 0% | 37.3 | 14,987 | Common Stock |
| Intra-Cellular Therapies Inc | Richard A. Lerner | Director | Grant, award, or other acquisition of securities at price $ 40.82 per share. | 30 Jun 2021 | 367 | 96,261 (0%) | 0% | 40.8 | 14,981 | Common Stock |
| Opko Health Inc | Richard A. Lerner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Intra-Cellular Therapies Inc | Richard A. Lerner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Intra-Cellular Therapies Inc | Richard A. Lerner | Director | Grant, award, or other acquisition of securities at price $ 33.93 per share. | 31 Mar 2021 | 442 | 95,894 (0%) | 0% | 33.9 | 14,997 | Common Stock |
| Intra-Cellular Therapies Inc | Richard A. Lerner | Director | Grant, award, or other acquisition of securities at price $ 25.66 per share. | 30 Sep 2020 | 584 | 94,981 (0%) | 0% | 25.7 | 14,985 | Common Stock |